Author

A. Barzel

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 4 Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 4 Approach:experimental assay· 4 Organism:mouse· 4 Assay:scRNA-seq· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell-cell communication· 1 Assay:CITE-seq· 1 Research Focus:clustering· 1

Frequent Co-Authors

A. D. Nahmad· 3 shared M. Horovitz-Fried· 3 shared I. Dotan· 2 shared Y. Carmi· 2 shared Y. Wine· 2 shared A. Ashkenazi· 1 shared A. Gleiberman· 1 shared A. Gutwillig· 1 shared

Activity by Year

2020-2023 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

A. D. Nahmad

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Expression of modified FcγRI enables myeloid cells to elicit robust tumor-specific cytotoxicity

Y. Carmi, L. Farhat-Younis, M. Na, A. Zarfin, N. Santana-Magal, A. Richter, A. Khateeb, A. Gutwillig, D. Rasoulouniriana, A. Gleiberman, L. Beck, T. Giger, A. Ashkenazi, A. Barzel, P. Rider

This study modifies myeloid cells to elicit tumor-specific cytotoxicity using chimeric receptors that signal through IgM and bind tumor antigens.

bioRxiv · Sep 30, 2023Immunology

Frequent Aneuploidy in Primary Human T Cells Following CRISPR-Cas9 cleavage

A. D. Nahmad, E. Reuveni, E. Goldschmidt, T. Tenne, M. Liberman, M. Horovitz-Fried, R. Khosravi, H. Kobo, E. Reinstein, A. Madi, U. Ben-David, A. Barzel

This study finds frequent aneuploidy and chromosomal truncations in CRISPR-Cas9-edited primary human T cells, associated with reduced proliferation and p53 activation.

bioRxiv · Aug 20, 2021Bioengineering

In vivo engineered B cells retain memory and secrete high titers of anti-HIV antibodies in mice

A. D. Nahmad, C. R. Lazzarotto, N. Zelikson, T. Kustin, M. Tenuta, D. Huang, I. Reuveni, M. Horovitz-Fried, I. Dotan, R. Rosin-Arbesfeld, D. Nemazee, J. E. Voss, A. Stern, S. Q. Tsai, A. Barzel

bioRxiv · Apr 8, 2021Immunology

Antibody repertoire analysis of tumor-infiltrating B cells reveals distinct signatures and distributions across tissues

L. Aizik, Y. Dror, D. Taussig, A. Barzel, Y. Carmi, Y. Wine

The paper analyzes the antibody repertoire of tumor-infiltrating B cells in a mouse model of triple-negative breast cancer, finding distinct signatures and migration patterns across tissues.

bioRxiv · Mar 17, 2021Immunology

B cells engineered to express an anti-HIV antibody allow memory retention, class switch recombination and clonal selection in mice

A. D. Nahmad, Y. Raviv, M. Horovitz-Fried, I. Sofer, T. Akriv, D. Nataf, I. Dotan, D. Burstein, Y. Wine, I. Benhar, A. Barzel

This study shows engineered B cells expressing anti-HIV antibodies can persist in mice, undergo class switch recombination, and show clonal selection after immunization.

bioRxiv · Feb 28, 2020Immunology